Voices of expectation for expansion of infertility treatment insurance coverage Opinions calling for flexible response are also available at 21:26 on September 22
k10012629601_202009222123_202009222125.mp4
Interest in infertility treatment is increasing year by year, and while the number of treatments is increasing, the use of national support systems is sluggish.
According to the NPO "Fine", which supports the parties involved in fertility treatment, the current fertility treatment is so-called "made-to-order" according to each person's physical condition, and the frequency of going to the hospital, the amount and type of medicine, etc. It depends greatly on.
There are also concerns that the scope of treatment will be limited and the chances of getting pregnant will decrease depending on the conditions set when expanding insurance coverage.
Akiko Matsumoto, the chairman of the NPO, said, "We welcome the expansion of insurance coverage, but we are very worried about whether we will continue to provide detailed treatment tailored to each individual's circumstances. Pregnancy and childbirth that the parties desire to receive insurance coverage. It must be tied to the above, "and demands a flexible response.
Another issue is that the information on choosing a medical institution is not sufficiently provided, such as the disclosure of the success rate of pregnancy for each medical institution has not progressed.
This means that some women will go to multiple medical institutions.
Mr. Matsumoto said, "There are more than 600 medical institutions that can perform in vitro fertilization, but detailed data and treatment results are not disclosed uniformly. It is difficult to choose where to go, and in some cases it costs millions of yen." I'm talking.
In addition, he points out that it is necessary to support people who want to become pregnant in society as a whole, saying that it is essential to create a work environment that makes it easy to balance treatment and work because treatment will require many visits to medical institutions. ..
Use of national support system is sluggish
Interest in infertility treatment is increasing year by year, and while the number of treatments is increasing, the use of national support systems is sluggish.
According to the Japan Society of Obstetrics and Gynecology, the number of "in vitro fertilization" performed was more than 110,000 in 2004, but it has increased year by year and quadrupled to more than 440,000 in 2017. ..
The number of children born by infertility treatment "in vitro fertilization" has also increased from more than 18,100 to about 56,600 over the same period.
In 2017, it will be 1 in 16 children born in a year.
On the other hand, the use of the support system by the government is sluggish.
According to the Ministry of Health, Labor and Welfare, the number of uses of the national support system that subsidizes the cost of infertility treatment peaked at more than 160,000 in 2015 and has continued to decline, reaching about 140,000 in 2017.
The last national survey on how much fertility treatment would cost was not done in 1998.
The Ministry of Health, Labor and Welfare is conducting a fact-finding survey this year, and will consider expanding insurance coverage based on the survey results that will be finalized within the fiscal year, but the study can be accelerated by the policy of Prime Minister Suga. There is sex.
“Total treatment cost of 1 million yen or more” Half of the total
The NPO "Fine", which supports the parties concerned, conducts multiple questionnaire surveys on how much it costs to treat infertility.
Of these, more than half of the respondents answered that the total treatment cost from the start of the hospital visit was more than 1 million yen.
In a detailed breakdown,
▽ 3 million yen or more and less than 5 million yen accounted for 12% of the total,
▽ 5 million yen or more also 7%,
and about 20% of the total cost 3 million yen or more.
The cost of infertility treatment tends to be higher, and the percentage of respondents who said it cost more than 3 million yen increased by 7 points from the 2010 survey 10 years ago.
Infertility treatment while working 16% leave work
According to a survey conducted by the Ministry of Health, Labor and Welfare three years ago, 16% of those who received fertility treatment while working were unable to balance their work and left their jobs.
When asked in multiple answers why they find it difficult to balance fertility treatment and work,
49% of the
respondents answered that they had to go to the
hospital frequently,
48% answered that they had a heavy mental burden, and
▽ of work. 36% said it was difficult to adjust the schedule.
On the other hand, in a survey of companies conducted at the same time, 69% of the companies answered that there was no support system or initiative for employees receiving fertility treatment.
Insurance coverage for infertility treatment Overseas
[French fertility treatment] In
France, public insurance is also applied to artificial insemination and in vitro fertilization if required by a doctor's diagnosis.
Applicable up to 6 times for artificial insemination and 4 times for in vitro fertilization.
As a general rule, the target age is until the woman's 43rd birthday.
Even after you become pregnant once, you can take the same number of times again if your doctor deems it necessary.
There is no income limit.
[German infertility treatment] In
Germany, insurance is also applied to infertility treatment such as artificial insemination and in vitro fertilization.
Of these, ▽ artificial insemination is up to 8 times, depending on the treatment conditions, and ▽ in vitro fertilization is up to 3 times.
The target age is under 40 for women and under 50 for men.
If you are married, you will be required to submit a treatment plan in advance, but there is no income limit.